kras mutation and glutathion glynac Glutathione Depletion Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Isoform-Specific Destabilization of the Active – The roles of KRAS in
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC kras mutation and glutathion glynac Interplays of glucose metabolism in pancreatic ductal adenocarcinoma GlyNAC Supplementation Improves Glutathione Deficiency, JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



